References
- Almazroo OA, Miah KM, Venkataramanan R. 2017. Drug metabolism in the liver. Clin Liver Dis. 21(1):1–20.
- Androutsopoulos VP, Tsatsakis AM, Spandidos DA. 2009. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer. 9(9):187.
- Bahceci A, Paydas S, Tanriverdi K, Ergin M, Seydaoglu G, Ucar G. 2015. DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma. Tumour Biol. 36(3):2155–2161.
- Brooks-Wilson AR. 2013. Genetics of healthy aging and longevity. Hum Genet. 132(12):1323–1338.
- Caldecott KW. 2019. XRCC1 protein; Form and function. DNA Repair. 81:102664.
- Chielle EO, Fortuna PC, Maziero JS. 2016. Association between the glutathione S-transferase P1 (GSTP1) Ile105Val gene polymorphism in obese and overweight patients over 60 years. J Bras Patol Med Lab. 52:211–216.
- Dar A, Faryal R, Masood N. 2017. Possible association of a distinct combined Glutathione-S-transferase members with allergic asthma patients in Pakistan. Genes Dis. 4(2):111–115.
- Dato S, Soerensen M, De Rango F, Rose G, Christensen K, Christiansen L, Passarino G. 2018. The genetic component of human longevity: new insights from the analysis of pathway-based SNP-SNP interactions. Aging Cell. 17(3):e12755.
- Debrabant B, Soerensen M, Flachsbart F, Dato S, Mengel-From J, Stevnsner T, Bohr VA, et al. 2014. Human longevity and variation in DNA damage response and repair: study of the contribution of sub-processes using competitive gene-set analysis. Eur J Hum Genet. 22(9):1131–6113.
- Di Pietro G, Magno LAV, Rios-Santos F. 2010. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol. 6(2):153–170.
- Dylawerska A, Barczak W, Wegner A, Golusinski W, Suchorska WM. 2017. Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review. Med Oncol. 34(12):197.
- Esalmi S, Sahebrak A. 2014. Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies. Curr. Hypertens. Res. 16(6):432.
- Fontana L, Bosviel R, Delort L, Guy L, Chalabi N, Kwiatkowski F. 2008. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res. 28(3B):1853–1856.
- Franceschi C, Garagnani P, Olivieri F, Salvioli S, Giuliani C. 2020. The contextualized genetics of human longevity: JACC focus seminar. J Am Coll Cardiol. 75(8):968–979.
- Gems D, Partridge L. 2013. Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol. 75:621–644.
- Hu Z, Wang Y, Wang X, Liang G, Miao X, Xu Y, Tan W, Wei Q, et al. 2005. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer. 115(3):478–483.
- Khabaz MN. 2014. Polymorphism of the glutathione S-transferase P1 gene (GST-pi) in breast carcinoma. Pol J Pathol. 65(2):141–146.
- Kim YJK, Kim HS, Seo YR. 2018. Genomic approach to understand the association of DNA repair with longevity and healthy aging using genomic databases of oldest-old population. Oxid Med Cell Longev. 2018:2984730.
- Langie SAS, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A, Azqueta A, et al. 2015. Causes of genome instability: the effect of low dose chemical exposures in modern society. CARCIN. 36(Suppl 1):S61–S88.
- Liu HX, Li J, Ye BG. 2016. Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer. Genet Mol Res. 15(4):gmr15048813.
- López-Cima MF, Álvarez-Avellón SM, Pascual T, Fernández-Somoano A, Tardón A. 2012. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias. BMC Cancer. 12:433.
- Lu DY, Che JY, Lu TR, Lu Y, Huang YK, Lu TL, Chen YZ, et al. 2018. Pathology and treatments of obesity. Trends Med. 18(5):1–2.
- Moghaddam AS, Nazarzadeh M, Nooroozi R, Darvish H, Jarrahi AM. 2016. XRCC1 and OGG1 gene polymorphisms and breast cancer: a systematic review of literature. Iran J Cancer. 9(1):e3467.
- Muiras ML, Verasdonck PV, Cottet F, Schächter F. 1998. Lack of association between human longevity and genetic polymorphisms in drug-metabolizing enzymes at the NAT2, GSTM1 and CYP2D6 loci. Hum Genet. 102(5):526–532.
- Nebert DW, Vasiliou V. 2004. Analysis of the glutathione S-transferase (GST) gene family. Hum Genomics. 1(6):460–464.
- Nijiati M, Saidaming A, Qiao J, Cheng Z, Qiu C, Sun Y. 2013. GNB3, eNOS, and mitochondrial DNA polymorphisms correlate to natural longevity in a xinjiang uygur population. PLoS One. 8(12):e81806.
- Ruiz JR, Fiuza-Luces C, Buxens A, Cano-Nieto A, Gómez-Gallego F, Santiago C, Rodríguez-Romo G, et al. 2012. Are centenarians genetically predisposed to lower disease risk? Age. 34(5):1269–1283.
- Santovito A, Gendusa C, Matini A, Ferraro F, Musso I, Costanzo M, Delclos A, Cervella P. 2017. Frequency distribution of six cytokine gene polymorphisms in North- and South-Italy. Int J Immunogenet. 44(4):158–163.
- Santovito A, Galli G, Ruberto S. 2019. Evaluation of the possible association of body mass index and four metabolic gene polymorphisms with longevity in an Italian cohort: a role for APOE, eNOS and FTO gene polymorphisms. Ann Hum Biol. 46(5):425–429.
- Seripa D, Pilotto A, Panza F, Matera MG, Pilotto A. 2010. Pharmacogenetics of cytochrome P450 (CYP) in the elderly. Ageing Res Rev. 9(4):457–474.
- Taioli E, Mari D, Franceschi C, Bonafè M, Monti D, Bertolini S, Marinelli D, Garte S. 2001. Polymorphisms of Drug-Metabolizing Enzymes in Healthy Nonagenarians and Centenarians: Difference at GSTT1 Locus. Biochem Biophys Res Commun. 280(5):1389–1392.
- Tian X, Seluanov A, Gorbunova V. 2017. Molecular mechanisms determining lifespan in short- and long-lived species. Trends Endocrinol Metab. 28(10):722–734.
- Wauthier V, Verbeeck RK, Calderon PB. 2007. The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly. Curr Med Chem. 14(7):745–757.
- Wei XP, Hu J. 2015. Cytochrome P450 1A1 exon 7 polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review. Onco Targets Ther. 8:1611–1618.
- Xu L, Wei H. 2015. Association between CYP1A1 2454A>G polymorphism and colorectal cancer risk: a meta-analysis. J Can Res Ther. 11(4):760–764.